Merck Manual

Please confirm that you are a health care professional

honeypot link

Transdermal and Vaginal Ring Hormonal Contraceptives


Frances E. Casey

, MD, MPH, Virginia Commonwealth University Medical Center

Reviewed/Revised Feb 2022 | Modified Sep 2022
View Patient Education

A quick-start protocol, similar to that used for oral contraceptives (OCs), can be used for transdermal (patch) and vaginal ring contraceptives. If either contraceptive method is started at any time other than the first 5 days of menses, a backup contraceptive method should be used concurrently for 7 days.

Adherence is typically better with the patch or ring than with OCs.

Spotting or breakthrough bleeding is uncommon when transdermal or ring contraception is used. Irregular bleeding becomes more common the longer women use transdermal or ring contraception.

Transdermal contraceptives

A 20-cm2 transdermal patch delivers 150 mcg of the progestin norelgestromin (the active metabolite of norgestimate) and 20 mcg of ethinyl estradiol daily into the systemic circulation for 7 days. After 1 week, the patch is removed, and a new patch is applied to a different area of the skin. After 3 patches are used, no patch is used for the 4th week to allow for withdrawal bleeding.

Hormone blood levels of estrogen and progestin are much more constant with the patch than with oral contraceptives (OCs). Overall, contraceptive efficacy, incidence of bleeding, and adverse effects with the patch are similar to those with OCs, but patient adherence may be better with the patch because it is applied weekly rather than taken daily. The patch may be less effective in women who weigh > 90 kg or have a body mass index (BMI) ≥ 30.

Women should be advised to use a backup contraceptive method concurrently for 7 days if > 2 days have elapsed since a new patch was to be applied.

Vaginal ring contraceptives

Vaginal rings are flexible, soft, and transparent. Two types of rings are available:

  • A month-long ring that releases 15 mcg of ethinyl estradiol (estrogen) and 120 mcg of etonogestrel (progestin) a day and must be replaced each month

  • A year-long ring that releases 13 mcg ethinyl estradiol (estrogen) and 150 mcg segesterone acetate (progestin) a day and must be replaced only once a year

Both types of rings are typically left in place for 3 weeks, then removed for 1 week to allow for withdrawal bleeding. The year-long ring is removed, and then the same ring is reinserted.

The hormones released by vaginal rings are absorbed through the vaginal epithelium. When a vaginal ring is used, hormone blood levels are relatively constant.

Women insert and remove the ring themselves; no fitting by a physician is required.

Contraceptive efficacy and adverse effects with vaginal rings are similar to those of OCs Adverse Effects Oral contraceptives (OCs) mimic ovarian hormones. Once ingested, they inhibit the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus, thus inhibiting the release of the pituitary... read more , but adherence may be better with rings because they are inserted monthly rather than taken daily.

Women may wish to remove the vaginal ring at times other than after 3 weeks. However, if the ring is removed for > 3 hours, women should be advised to use a backup contraceptive method concurrently for 7 days.

Drugs Mentioned In This Article

Drug Name Select Trade
Implanon, Nexplanon
View Patient Education
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz!